Novel Carrier Peptide
A cell penetrating peptide designated Xentry derived from the X-protein of the hepatitis B virus
It is small compared to other known peptides, therefore costs of goods are lower. Uptake is more controllable.
Therapeutic or life sciences tool platform
40704
PCT/NZ2011/000102
We have identified a novel cell penetrating peptide designated Xentry derived from the X-protein of the hepatitis B virus. It is the smallest known carrier peptide -only 5 amino acids in length. It holds a therapeutic advantage in that it is not taken up by non-adherent cells, hence will not be sequestered and diluted by blood cells following injection, thereby enabling more efficient targeting of tissues.
1656099
New Zealand
